PL211492A1 - Sposob wytwarzania nowych glikozydowych pochodnych pleuromutyliny - Google Patents

Sposob wytwarzania nowych glikozydowych pochodnych pleuromutyliny

Info

Publication number
PL211492A1
PL211492A1 PL21149278A PL21149278A PL211492A1 PL 211492 A1 PL211492 A1 PL 211492A1 PL 21149278 A PL21149278 A PL 21149278A PL 21149278 A PL21149278 A PL 21149278A PL 211492 A1 PL211492 A1 PL 211492A1
Authority
PL
Poland
Prior art keywords
pleuromutylin
making new
glycoside derivatives
new glycoside
derivatives
Prior art date
Application number
PL21149278A
Other languages
English (en)
Other versions
PL123850B1 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL211492A1 publication Critical patent/PL211492A1/pl
Publication of PL123850B1 publication Critical patent/PL123850B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL1978211492A 1977-12-08 1978-12-06 Process for preparing novel glycoside derivatives of pleuromutilin PL123850B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/858,507 US4130709A (en) 1977-12-08 1977-12-08 Pleuromutilin glycoside derivatives

Publications (2)

Publication Number Publication Date
PL211492A1 true PL211492A1 (pl) 1979-11-19
PL123850B1 PL123850B1 (en) 1982-12-31

Family

ID=25328471

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978211492A PL123850B1 (en) 1977-12-08 1978-12-06 Process for preparing novel glycoside derivatives of pleuromutilin

Country Status (28)

Country Link
US (1) US4130709A (pl)
EP (1) EP0002588B1 (pl)
JP (1) JPS5498751A (pl)
AT (1) AT362065B (pl)
AU (1) AU524665B2 (pl)
BE (1) BE872489A (pl)
CA (1) CA1109866A (pl)
CH (1) CH639103A5 (pl)
CS (2) CS219344B2 (pl)
DD (1) DD139858A5 (pl)
DE (1) DE2862226D1 (pl)
DK (1) DK539578A (pl)
ES (1) ES475854A1 (pl)
FI (1) FI783709A (pl)
FR (1) FR2411205A1 (pl)
GB (1) GB2009738B (pl)
GR (1) GR72774B (pl)
HU (1) HU181429B (pl)
IE (1) IE47533B1 (pl)
IL (1) IL56115A (pl)
IT (1) IT1160316B (pl)
LU (1) LU80619A1 (pl)
PL (1) PL123850B1 (pl)
PT (1) PT68857A (pl)
RO (3) RO84425B (pl)
SU (1) SU902666A3 (pl)
YU (1) YU281878A (pl)
ZA (1) ZA786872B (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5594359A (en) * 1979-01-12 1980-07-17 Sandoz Ag Novel pleuromutilin derivatives*their manufacture and use
US5041534A (en) * 1983-03-22 1991-08-20 Merrell Dow Pharmaceuticals Process for preparing antibiotic L 17054
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
US5077398A (en) * 1986-11-18 1991-12-31 Merck & Co., Inc. Process for isolation of avermectin B1 components with improved purity and subsequent isolaton of B2 components
US5696096A (en) * 1990-09-28 1997-12-09 Bristol-Myers Squibb Company Pradimicin derivatives
US5843908A (en) * 1990-09-28 1998-12-01 Bristol-Myers Squibb Company Pradimicins l and fl, and derivatives thereof
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
JP3816570B2 (ja) * 1996-02-16 2006-08-30 塩水港精糖株式会社 アシル化剤
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
EP2181995A3 (en) 2003-09-03 2010-06-16 Glaxo Group Limited Salts and crystalline form of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-sufanyl)-acetate
US6838576B1 (en) 2003-10-23 2005-01-04 3M Innovative Properties Company Process for preparing functional group-containing olefinic compounds
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
US7998927B2 (en) * 2006-06-23 2011-08-16 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US8084022B2 (en) 2006-06-23 2011-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US8173594B2 (en) * 2006-06-23 2012-05-08 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US20090326193A1 (en) * 2006-06-23 2009-12-31 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
EP1972618A1 (en) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
JP5613657B2 (ja) 2008-03-28 2014-10-29 ヘイル バイオファーマ ベンチャーズ,エルエルシー ベンゾジアゼピン組成物の投与
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
EP3193946A4 (en) * 2014-09-19 2018-05-23 Emory University Saccharide analogs and agents for the diagnosis and therapy of bacterial infections

Also Published As

Publication number Publication date
RO84426A (ro) 1984-06-21
FI783709A (fi) 1979-06-09
CS219342B2 (en) 1983-03-25
IL56115A0 (en) 1979-03-12
RO80082B (ro) 1983-01-30
CS219344B2 (en) 1983-03-25
GB2009738A (en) 1979-06-20
FR2411205B1 (pl) 1981-08-14
IT1160316B (it) 1987-03-11
IE782421L (en) 1979-06-08
DD139858A5 (de) 1980-01-23
ZA786872B (en) 1980-08-27
GR72774B (pl) 1983-12-05
BE872489A (fr) 1979-06-05
RO84425B (ro) 1984-08-30
DE2862226D1 (en) 1983-05-11
CA1109866A (en) 1981-09-29
JPS5498751A (en) 1979-08-03
ATA871578A (de) 1980-09-15
HU181429B (en) 1983-07-28
AU4216278A (en) 1979-06-14
PT68857A (en) 1979-01-01
YU281878A (en) 1983-06-30
IE47533B1 (en) 1984-04-18
RO84425A (ro) 1984-06-21
CH639103A5 (fr) 1983-10-31
RO84426B (ro) 1984-08-30
DK539578A (da) 1979-07-05
AT362065B (de) 1981-04-27
LU80619A1 (fr) 1979-06-05
FR2411205A1 (fr) 1979-07-06
ES475854A1 (es) 1980-05-16
EP0002588B1 (en) 1983-04-06
IT7830657A0 (it) 1978-12-06
GB2009738B (en) 1982-11-10
IL56115A (en) 1984-01-31
PL123850B1 (en) 1982-12-31
EP0002588A1 (en) 1979-06-27
AU524665B2 (en) 1982-09-30
US4130709A (en) 1978-12-19
RO80082A (ro) 1983-02-01
SU902666A3 (ru) 1982-01-30

Similar Documents

Publication Publication Date Title
PL211492A1 (pl) Sposob wytwarzania nowych glikozydowych pochodnych pleuromutyliny
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL204549A1 (pl) Sposob wytwarzania pochodnych pirolidyny
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL204550A1 (pl) Sposob wytwarzania pochodnych pirolidyny
PL211196A1 (pl) Sposob wytwarzania o-podstawionych pochodnych (+)-cyjanidanolu-3
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL206810A1 (pl) Sposob wytwarzania nowych pochodnych alkilenodwuaminy
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL204616A1 (pl) Sposob wytwarzania pochodnych 1-oksadetiacefamowych
PL208757A1 (pl) Sposob wytwarzania pochodnych izochinoliny
PL208701A1 (pl) Sposob wytwarzania nowych pochodnych nitrozomocznika
PL205497A1 (pl) Sposob wytwarzania nowych pochodnych morfiny
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL207625A1 (pl) Sposob wytwarzania nowych pochodnych nitrozomocznika
PL211409A1 (pl) Sposob wytwarzania nowych podstawionych pirolidyn
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL215005A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL205741A1 (pl) Sposob wytwarzania nieglikozydowych pochodnych cukrowych teofiliny
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2